Brief: Amgen Inc. Reports 23.2% Stake In Neumora Therapeutics As Of September 19- SEC Filing
Sept 27 (Reuters) - Amgen Inc AMGN.O :
* AMGEN INC. REPORTS 23.2% STAKE IN NEUMORA THERAPEUTICS AS
OF
SEPTEMBER 19- SEC FILING
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neumora Therapeutics
See all newsNeumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex